1. Home
  2. CGC vs EMBC Comparison

CGC vs EMBC Comparison

Compare CGC & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canopy Growth Corporation

CGC

Canopy Growth Corporation

N/A

Current Price

$0.43

Market Cap

299.0M

Sector

Health Care

ML Signal

N/A

Logo Embecta Corp.

EMBC

Embecta Corp.

N/A

Current Price

$6.05

Market Cap

354.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CGC
EMBC
Founded
N/A
1924
Country
Canada
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
299.0M
354.1M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
CGC
EMBC
Price
$0.43
$6.05
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
★ $4.00
AVG Volume (30 Days)
★ 2.5M
719.9K
Earning Date
11-06-2026
11-24-2026
Dividend Yield
N/A
★ 0.65%
EPS Growth
★ 84.17
20.90
EPS
N/A
★ 1.03
Revenue
★ $12,759,000.00
N/A
Revenue This Year
$18.91
N/A
Revenue Next Year
$6.82
$5.59
P/E Ratio
★ N/A
$6.00
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$2.77
52 Week High
$2.38
$14.78

Technical Indicators

Market Signals
Indicator
CGC
EMBC
Relative Strength Index (RSI) 19.41 43.28
Support Level N/A $5.64
Resistance Level $1.08 $6.85
Average True Range (ATR) 0.05 0.36
MACD -0.01 -0.07
Stochastic Oscillator 0.54 19.31

Price Performance

Historical Comparison
CGC
EMBC

About CGC Canopy Growth Corporation

Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: